Articles

Wall Street grows more optimistic about Tesla sales. Should you?

China sales are likely to be the highlight of Tesla’s upcoming deliveries data.

PayPal’s stock is having its best year since 2020, and this is a big reason why

When PayPal CEO Alex Chriss took over a year ago, investors questioned whether the company had a future. Now he says product innovations have helped change the conversation.

Treasury yields edge lower ahead of PCE inflation report

Bond yields edged lower Friday as traders awaited a U.S. inflation report.

German firm blames transcription error for discrepancy spotted by short seller

The German company under fire from a short seller on Friday said a transcription error was the cause for a discrepancy in its cash balances.

Billy Joel is finally selling his huge Florida mansion after 6 years of trying

Sitting on 1.61 acres, this Mediterranean-style beauty boasts a jaw-dropping 13,349 square feet of pure grandeur spread across 3 stories

Actress Jameela Jamil and singer James Blake are still trying to sell their L.A. home—now for $6.35 million

The couple have cut the price of the 6,934-square-foot home yet again in the hopes of finally offloading it.

Chinese stocks could surge higher as investors get ‘FOMO,’ Goldman Sachs says

International investors are getting increasingly concerned about missing out on the rally that was sparked by the unveiling of the People’s Bank of China’s far-reaching stimulus package on Tuesday

Bristol-Myers Squibb stock jumps on schizophrenia drug approval

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.

Satellite-TV rivals DirecTV, Dish reportedly in advanced merger talks

The Wall Street Journal reported DirecTV could acquire rival Dish, creating one of the nation’s largest pay-TV providers, in a deal that could be announced as soon as Monday.

China ETFs set for best week on record after Beijing fires policy ‘bazooka’ to boost economy. Is it time to jump in? 

China ETFs have surged on the back of a blitz of stimulus measures by the country’s government to revive the world’s second-largest economy.

Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims

Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.

Alphabet’s stock has never been this cheap relative to Meta’s. How to play that.

A Bernstein analyst says it’s still “difficult to defend” pitching Alphabet shares with conviction given various regulatory and competitive risks.
1 997 998 999 1,000 1,001 2,569